Skip to content

Neonatal TSH RIA Kit (125I)

by Diagnostic Products Corp.

510(k) K772192

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK772192 Date12 Jan 1978ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JLW
Device Class
Class II
Regulation
21 CFR Part 862.1690
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Neonatal TSH RIA Kit (125I) is a radioimmunoassay device used for measuring thyroid-stimulating hormone (TSH) in neonatal specimens. It is classified as a Class 2 device under the Clinical Chemistry medical specialty.

The device was cleared by the FDA through the traditional 510(k) pathway under K772192 on January 12, 1978, and is substantially equivalent to a predicate device. It is manufactured by Diagnostic Products Corp. and assigned product code JLW.

Other devices from Diagnostic Products Corp.

See all devices from Diagnostic Products Corp. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Neonatal TSH RIA Kit (125I) used for?

    The Neonatal TSH RIA Kit (125I) is used for measuring thyroid-stimulating hormone (TSH) in neonatal specimens. It is a radioimmunoassay device designed specifically for this clinical chemistry application in newborn screening.

  • How is the Neonatal TSH RIA Kit (125I) supplied and what is its intended use?

    The device is supplied as a radioimmunoassay kit for in vitro diagnostic use. It is intended to measure TSH levels in neonatal blood samples to assist in the detection of congenital hypothyroidism, based on its cleared intended use as a Class 2 clinical chemistry device.

  • What regulatory pathway was used for the Neonatal TSH RIA Kit (125I) and what is its classification?

    The Neonatal TSH RIA Kit (125I) was cleared through the FDA's traditional 510(k) pathway under submission K772192 on January 12, 1978. It is classified as a Class 2 device under the Clinical Chemistry medical specialty with product code JLW.